Rouxinlin

Ruoxinlin (generic name toludesvenlafaxine or ansofaxine) is a novel oral serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) developed by Luye Pharma Group as an innovative antidepressant for treating major depressive disorder